ConductScience.org, home

Paper41528341

Optimizing delivery of an anti-cytomegalovirus inhibitory peptide using a cell-penetrating peptide.

Beeton K and 4 others. J Gen Virol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Optimizing delivery of an anti-cytomegalovirus inhibitory peptide using a cell-penetrating peptide. Papers, record 41528341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41528341

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimizing delivery of an anti-cytomegalovirus inhibitory peptide using a cell-penetrating peptide.
PubMed
Journal
J Gen Virol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beeton KKomal
2Haskell JPJacob P
3Mitra DDipanwita
4Taylor EBErin B
5Bidwell GLGene L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell-Penetrating PeptidesMajor topic
Antiviral AgentsMajor topic
CytomegalovirusMajor topic
Cytomegalovirus InfectionsMajor topic
Animals
Mice
Humans
Muromegalovirus
Mice, Inbred BALB C
Elastin-Like Polypeptides
Female
Disease Models, Animal
Elastin
Cell Line

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U54 HL169191NHLBI NIH HHSUnited StatesU54HL169191PubMed

Source NIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118627655Gastrointestinal cytomegalovirus disease in the immunocompromised patient.Curr Gastroenterol Rep2008https://conductscience.org/library/papers/18627655PubMed
212782241The human cytomegalovirus.Pharmacol Ther2003https://conductscience.org/library/papers/12782241PubMed
328355091Cytomegalovirus Retinitis: A Review.J Ocul Pharmacol Ther2017https://conductscience.org/library/papers/28355091PubMed
432508641Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.Front Pharmacol2020https://conductscience.org/library/papers/32508641PubMed
525993081Cytomegalovirus infection in renal transplantation: clinical aspects, management and the perspectives.Einstein (Sao Paulo)2015https://conductscience.org/library/papers/25993081PubMed
618720260Congenital CMV infection: prevalence in newborns and the impact on hearing deficit.Scand J Infect Dis2008https://conductscience.org/library/papers/18720260PubMed
740870880Hearing Loss in Infants and Children with Asymptomatic Congenital Cytomegalovirus Infection: An Update in Diagnosis, Screening and Treatment.Diagnostics (Basel)2025https://conductscience.org/library/papers/40870880PubMed
84474024The synthetic polypentapeptide of elastin coacervates and forms filamentous aggregates.Biochim Biophys Acta1974https://conductscience.org/library/papers/4474024PubMed
921827432Antiviral treatment of cytomegalovirus infection.Infect Disord Drug Targets2011https://conductscience.org/library/papers/21827432PubMed
1011243966Pulmonary cytomegalovirus infection in immunocompromised patients.Chest2001https://conductscience.org/library/papers/11243966PubMed
1111435566Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third.J Virol2001https://conductscience.org/library/papers/11435566PubMed
1228398680Cytomegalovirus infection in pregnancy.Birth Defects Res2017https://conductscience.org/library/papers/28398680PubMed
1325316174Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Rev Med Virol2014https://conductscience.org/library/papers/25316174PubMed
148312047A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.AIDS Res Hum Retroviruses1993https://conductscience.org/library/papers/8312047PubMed
1511215290Investigation of CMV disease in immunocompromised patients.J Clin Pathol2001https://conductscience.org/library/papers/11215290PubMed
1634402743Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs.Tissue Barriers2022https://conductscience.org/library/papers/34402743PubMed
1738704431An Elastin-like Polypeptide-fusion peptide targeting capsid-tegument interface as an antiviral against cytomegalovirus infection.Sci Rep2024https://conductscience.org/library/papers/38704431PubMed
1831786977Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia.Hypertension2020https://conductscience.org/library/papers/31786977PubMed
1925747982Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.Biol Pharm Bull2015https://conductscience.org/library/papers/25747982PubMed
2034181768Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.Clin Transplant2021https://conductscience.org/library/papers/34181768PubMed

See all 61 referencesDownload CSV of references

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41528341

GET https://conductscience.org/api/papers/v1/41528341/references?page=2